Drugs a ad-ae
| Drug Name | Add To My List | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adalimumab | |||||||||||
HUMIRA
|
|||||||||||
| Adapalene | |||||||||||
DIFFERIN GEL
|
|||||||||||
DIFFERIN CREAM
|
|||||||||||
DIFFERIN LOTION
|
|||||||||||
EPIDUO GEL
|
|||||||||||
DIFFERIN GEL 0.1%
|
|||||||||||
EPIDUO FORTE GEL
|
|||||||||||
| Adefovir | |||||||||||
HEPSERA
|
|||||||||||
| Adenosine | |||||||||||
Adenosine Prefilled Syringes
|
|||||||||||
Adenosine Vials
|
|||||||||||
| Ado-trastuzumab | |||||||||||
KADCYLA
|
|||||||||||
Endocrinology Advisor Articles
- Fasting Glycemic Variability Indicates Increased Risk for Type 2 Diabetes
- Vegan Diet Associated With Weight Loss and Reduced Insulin Resistance
- Exercise After Overnight Fasting Stabilizes Glucose Levels in Type 1 Diabetes
- Heritability of BMI Stronger in Obesogenic Environments
- Obesity in Adolescent Girls Associated With Negative Outcomes in Adulthood
- Updated ADA, EASD Consensus Guidelines for Managing Hyperglycemia in T2D
- Vegan Diet Associated With Weight Loss and Reduced Insulin Resistance
- Insulins
- Light Therapy Offers Nonpharmacologic Treatment for Perimenopausal Depression
- Muscle Cell Profiles Relate to Exercise Response Variation in Type 2 Diabetes
- Levonorgestrel-Releasing Intrauterine System Approved for 5-Year Use
- Addressing Ethical Challenges Associated With Precision Medicine
- Unapproved Active Pharmaceuticals Identified in Many Dietary Supplements
- Periodic Fasting May Reduce Medication Use in T2D
- Heritability of BMI Stronger in Obesogenic Environments
Sign Up for Free e-Newsletters
Check out what's trending
CME Focus
Blocking TSH-Receptor Antibodies in Autoimmune Thyroid Disease
CME|CE
4.00 Credits
Discussion Guide - Guidelines for Treating Type 2 Diabetes
CME
1.00 Credits